The Swiss-Dutch fragrance and flavor specialist may have outperformed expectations in the first six months of 2025, but it expects EBITDA for the full year to be slightly below its initial forecasts… The cause is exchange rate volatility…
Despite a strong first half of 2025, DSM-Firmenich is cautious about the full year.
The Swiss fragrance and flavor specialist, created in mid-2023 from the merger of Firmenich and Dutch nutrition specialist DSM, performed well in the first six months of the year.
Good performance in the first half
“We are pleased to report a good performance in the first half, with good organic sales and profit growth and the effective implementation of our strategic plan,” said Dimitri de Vreeze, CEO of the company, which supplies the perfume divisions of major French luxury groups LVMH and Kering, in a statement released on July 31. Thanks to our combined capabilities, we continue to make satisfactory progress in implementing global cost and revenue synergies across all our businesses, demonstrating the success of our merger.”
Discover our plans Subscribe for 1€ Become an active member of the community of luxury leaders.
To continue reading this article, subscribe or log in to your account
Read also > Interparfums has had a good first half
Featured photos: © DSM-Firmenich
